Literature DB >> 3090712

Two to three days treatment of typhoid fever with ceftriaxone.

C K Lan, D L Cheng, R Lasserre.   

Abstract

Pharmacokinetic properties of ceftriaxone, such as sustained tissue drug levels over 24 hours after a single injection; good penetration of the antibiotic into cells; significant biliary excretion as active unchanged compound and high potency against S. typhi, should make it possible to significantly shorten the treatment of typhoid fever. To test this hypothesis a pilot, open study was initiated. 17 adult patients suffering from uncomplicated typhoid or paratyphoid fever, documented by blood culture, were treated with 4g ceftriaxone once daily for three days (4 patients) or two days (15 patients). The cure rate of 17 assessable patients was 94.2% (one failure). One possible relapse was observed two months after treatment. It is to be noted that no patient in the study suffered from a severe form of the disease.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3090712

Source DB:  PubMed          Journal:  Southeast Asian J Trop Med Public Health        ISSN: 0125-1562            Impact factor:   0.267


  4 in total

Review 1.  Ceftriaxone. A reappraisal of its antibacterial activity and pharmacokinetic properties, and an update on its therapeutic use with particular reference to once-daily administration.

Authors:  R N Brogden; A Ward
Journal:  Drugs       Date:  1988-06       Impact factor: 9.546

2.  Treatment of typhoid fever with ceftriaxone for 5 days or chloramphenicol for 14 days: a randomized clinical trial.

Authors:  A Islam; T Butler; I Kabir; N H Alam
Journal:  Antimicrob Agents Chemother       Date:  1993-08       Impact factor: 5.191

3.  Pharmacokinetics of ceftriaxone in patients with typhoid fever.

Authors:  G Acharya; C Crevoisier; T Butler; M Ho; M Tiwari; K Stoeckel; C A Bradley
Journal:  Antimicrob Agents Chemother       Date:  1994-10       Impact factor: 5.191

4.  Interleukin-6, gamma interferon, and tumor necrosis factor receptors in typhoid fever related to outcome of antimicrobial therapy.

Authors:  T Butler; M Ho; G Acharya; M Tiwari; H Gallati
Journal:  Antimicrob Agents Chemother       Date:  1993-11       Impact factor: 5.191

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.